Nanobiotix is trading $38.23 (+5.67%) up now, with no clear company-specific catalyst identified for August 11, 2026.

  • No fresh earnings release, major filing, or company announcement surfaced overnight.
  • Recent coverage centers on earlier clinical developments and analyst commentary, rather than August 11 news.
  • Broader indexes are modestly higher, but market gains remain below the threshold for a clear global explanation.